By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Wellcome Trust announced yesterday that its board has approved the creation of a new business to invest in emerging technologies in the healthcare and life sciences sector.

The new business, called Project Sigma for now, will have an initial investment of £200 million ($317 million), drawn from Wellcome Trust's endowment. A name and brand identity will be announced shortly, Wellcome Trust said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.